Literature DB >> 8153013

International variations in the incidence of childhood soft-tissue sarcomas.

C A Stiller1, D M Parkin.   

Abstract

In the study of international childhood cancer incidence coordinated by the International Agency for Research on cancer, soft-tissue sarcomas comprised between 4 and 8% of all cancers between 0 and 14 years of age. Among predominantly white populations, the age-standardised annual incidence rate (ASR) for all soft-tissue sarcomas was between 5 and 9 per million. The most common histological subtypes were rhabdomyosarcoma (ASR 4-7 per million) and fibrosarcoma, including other malignant fibromatous tumours (ASR 1-2 per million). In the United States the incidence of rhabdomyosarcoma for black girls was only half that for white girls, while the rates for boys were similar in the two ethnic groups; fibrosarcoma had a higher incidence among black people than white people for both sexes. Throughout most of Asia, soft-tissue sarcomas almost invariably had a total ASR below 6 per million, rhabdomyosarcoma and fibrosarcoma again being the most common histological types. In Africa, incidence rates could not generally be calculated, but there were substantial numbers of registrations for rhabdomyosarcoma and fibrosarcoma. The majority of cases of Kaposi's sarcoma were in African children, and in eastern and southern Africa where Kaposi's sarcoma is endemic among adult men it comprised 25-50% of soft-tissue sarcomas and 2-10% of all childhood cancers; the sex ratio (M/F) was 2.2:1, in contrast to the overwhelming male predominance among adults. Variations between ethnic groups in the incidence of rhabdomyosarcoma and fibrosarcoma, together with their occurrence in a number of heritable syndromes, suggest that genetic predisposition is important in their aetiology. There was little evidence for an environmental aetiology in rhabdomyosarcoma and fibrosarcoma but an infectious agent may be responsible for childhood Kaposi's sarcoma.

Entities:  

Mesh:

Year:  1994        PMID: 8153013     DOI: 10.1111/j.1365-3016.1994.tb00439.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  15 in total

1.  Costello syndrome: two cases with embryonal rhabdomyosarcoma.

Authors:  B Kerr; O B Eden; R Dandamudi; N Shannon; O Quarrell; A Emmerson; E Ladusans; M Gerrard; D Donnai
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

Review 2.  Cancer of childhood in sub-Saharan Africa.

Authors:  Cristina Stefan; Freddie Bray; Jacques Ferlay; Biying Liu; D Maxwell Parkin
Journal:  Ecancermedicalscience       Date:  2017-07-28

3.  Descriptive epidemiology of childhood cancer in Cali: Colombia 1977-2011.

Authors:  Luis Eduardo Bravo; Luz Stella García; Paola Collazos; Paula Aristizabal; Oscar Ramirez
Journal:  Colomb Med (Cali)       Date:  2013-09-30

4.  Incidence, and gender, age and ethnic distribution of sarcomas in the republic of suriname from 1980 to 2008.

Authors:  D Ra Mans; A E Budhu Lall; V L Macnack; J A van Tholl; E B Zandveld; M A Vrede
Journal:  West Indian Med J       Date:  2014-04-11       Impact factor: 0.171

5.  Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing.

Authors:  Françoise Ducimetière; Antoine Lurkin; Dominique Ranchère-Vince; Anne-Valérie Decouvelaere; Michel Péoc'h; Luc Istier; Philippe Chalabreysse; Christine Muller; Laurent Alberti; Pierre-Paul Bringuier; Jean-Yves Scoazec; Anne-Marie Schott; Christophe Bergeron; Dominic Cellier; Jean-Yves Blay; Isabelle Ray-Coquard
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

Review 6.  Urogenital tumours in childhood.

Authors:  S Swinson; K McHugh
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

7.  Malignant peripheral nerve sheath tumors in Africa: a clinicopathological study.

Authors:  Peter M Nthumba; Paul Irungu Juma
Journal:  ISRN Surg       Date:  2011-04-11

8.  GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma.

Authors:  S Gallego; D Bernabeu; M Garrido-Pontnou; G Guillen; N Hindi; A Juan-Ribelles; C Márquez; C Mata; J Orcajo; G Ramírez; M Ramos; C Romagosa; D Ruano; P Rubio; R Vergés; C Valverde
Journal:  Clin Transl Oncol       Date:  2021-07-01       Impact factor: 3.405

9.  Embryonal rhabdomyosarcoma in mastoid and middle ear in a 3-year-old girl: a rare case report.

Authors:  Saman Vegari; Alireza Hemati; Hosein Baybordi; Leila Davarimajd; Ghasem Chatrbahr
Journal:  Case Rep Otolaryngol       Date:  2012-06-18

10.  PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells.

Authors:  Diana Marklein; Ulrike Graab; Ivonne Naumann; Tiandong Yan; Rosalie Ridzewski; Frauke Nitzki; Albert Rosenberger; Kai Dittmann; Jürgen Wienands; Leszek Wojnowski; Simone Fulda; Heidi Hahn
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.